cannabis investing FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
cannabis investing FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)
cannabis investing FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange On Friday, March 6, 2020
cannabis investing Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara
cannabis investing FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
cannabis investing FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
cannabis investing Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors
cannabis investing FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on January 9, 2020
cannabis investing FSD Pharma to Present at 12th Annual LD Micro Main Event Investor Conference on December 11
Questcorp Mining Completes 25 Percent of Maiden Drilling Program at the La Union Gold & Silver Project in Mexico
Allied Critical Metals Closes Final Tranche of Over-Subscribed Non-Brokered Private Placement Upsized to $5.1 Million
